LONDON (Reuters) - Britain should conduct an independent assessment of a potential takeover of British pharmaceutical firm AstraZeneca by U.S. drugmaker Pfizer , the leader of the opposition Labour party Ed Miliband said on Sunday.
"(Prime Minister) David Cameron must get an independent assessment of the impact this bid will have on the long-term science and industrial base of this country," Miliband told the
BBC.
ASTRAZENECA (AZN.LO)rejected a 63 billion-pound ($106 billion)takeover bid from PFIZER (PFE.NY)on Friday, but the U.S. firm is expected to pursue its interest. ($1 = 0.5927 British Pounds)
(Reporting by William James; editing by Andrew Roche)
Relacionados
- Pfizer deberá subir su oferta o lanzar una opa hostil para hacerse con AstraZeneca
- AstraZeneca rechaza la nueva oferta de Pfizer, que valora la compañía en 76.755 millones
- AstraZeneca rechaza la nueva oferta de Pfizer, que valora la compañía en 76.755 millones
- Economía/Empresas.- AstraZeneca rechaza la nueva oferta de Pfizer, que valora la compañía en 76.755 millones
- Pfizer mejora su oferta sobre AstraZeneca hasta los 76.755 millones